Search clinical trials for: behavioral pharmacology
Total 18869 results
-
Johns Hopkins UniversityCompletedHealthyUnited States
-
Naurex, Inc, an affiliate of Allergan plcCompletedDepressive Disorder, MajorUnited States
-
Eli Lilly and CompanyCoLucid PharmaceuticalsCompletedMigraine With or Without AuraUnited States
-
Johns Hopkins UniversityCompleted
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
AllerganCompletedMigraine, With or Without AuraUnited States
-
Johns Hopkins UniversityWithdrawn
-
Joshua A. Lile, Ph.D.Completed
-
Johns Hopkins UniversityCompleted
-
Joshua A. Lile, Ph.D.CompletedActive Cocaine UsersUnited States
-
AllerganCompletedMigraine, With or Without AuraUnited States
-
Johns Hopkins UniversityRTI International; Substance Abuse and Mental Health Services Administration...Completed
-
Johns Hopkins UniversityHeffter Research InstituteCompletedCancer | Anxiety | Depressive SymptomsUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Exposure | Nicotine Withdrawal SuppressionUnited States
-
Yale UniversityCompletedAlcohol ReactivityUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine DependenceUnited States
-
National Institute on Drug Abuse (NIDA)CompletedOpioid Abuse | Opioid Addiction | Stimulant Abuse | Stimulant AddictionUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedHyperalgesiaUnited States
-
Avalo Therapeutics, Inc.Completed
-
William StoopsNational Institute on Drug Abuse (NIDA)Completed
-
Johns Hopkins UniversityCompletedOpiate Addiction | Mental and Behavioral Disorders Due to Use of Cocaine: Harmful UseUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedPain | Addiction | Opioid DependenceUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedChronic Pain | Opioid-Related DisordersUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedCocaine DependenceUnited States
-
SunovionCompleted
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedCaffeine Use Disorder (DSM-5 Condition for Further Study)United States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Johns Hopkins UniversityPfizerCompletedSubstance-Related Disorders | Smoking Cessation | RecurrenceUnited States
-
Johns Hopkins UniversityRTI International; Substance Abuse and Mental Health Services Administration...CompletedCannabis ToxicologyUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
Tufts Medical CenterNational Institute of Mental Health (NIMH)CompletedBipolar Disorder | Bipolar DepressionUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedOpioid Dependence | Opioid AbuseUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedCOCAINE-RELATED DISORDERSUnited States
-
Alcobra Ltd.TerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States, Israel
-
PfizerTerminatedGeneralized Anxiety DisorderUnited States
-
University of KentuckyNational Institute on Drug Abuse (NIDA)Completed
-
PfizerCompletedSmoking CessationUnited States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)Completed
-
Tufts Medical CenterPfizerCompletedDepression | Bipolar Disorder | Bipolar DepressionUnited States
-
PfizerGlaxoSmithKlineCompletedSmoking CessationUnited States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia, Argentina
-
Pain TherapeuticsCompletedOpioid-Related DisordersUnited States
-
Naurex, Inc, an affiliate of Allergan plcCompletedMajor Depressive DisorderUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Johns Hopkins UniversityFetzer Institute; The CSP Fund of the San Francisco FoundationCompleted
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive Disorder (MDD)United States
-
Bristol-Myers SquibbTerminatedDepressionFrance, South Africa, Sweden, United States, Australia, Italy, Argentina, Austria, Spain, Finland, India, Puerto Rico
-
Bristol-Myers SquibbCompletedDepressionFrance, Sweden, United States, South Africa, Canada, Finland
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed